| Satnam S Mahal, MD | |
|
1197 Highway Kk, Osage Beach, MO 65065-3344 | |
| (573) 348-5331 | |
| (573) 348-2393 |
| Full Name | Satnam S Mahal |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 45 Years |
| Location | 1197 Highway Kk, Osage Beach, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053399915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 105270 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Compass Health Inc | 1951206754 | 181 |
News Archive
UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer.
A new analysis has identified a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that African-American women may face obstacles to receiving appropriate breast cancer-related care.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
For women who have multiple miscarriages, the pain of repeated loss is often compounded by another reality. The causes behind miscarriage are complex and often difficult to identify, and even those conditions and associations proposed as causes are poorly understood.
› Verified 2 days ago
| Entity Name | Compass Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285619494 PECOS PAC ID: 1951206754 Enrollment ID: O20040408000955 |
News Archive
UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer.
A new analysis has identified a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that African-American women may face obstacles to receiving appropriate breast cancer-related care.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
For women who have multiple miscarriages, the pain of repeated loss is often compounded by another reality. The causes behind miscarriage are complex and often difficult to identify, and even those conditions and associations proposed as causes are poorly understood.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Satnam S Mahal, MD 2000 Hatton Ct, Columbia, MO 65203-5471 Ph: () - | Satnam S Mahal, MD 1197 Highway Kk, Osage Beach, MO 65065-3344 Ph: (573) 348-5331 |
News Archive
UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer.
A new analysis has identified a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that African-American women may face obstacles to receiving appropriate breast cancer-related care.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
For women who have multiple miscarriages, the pain of repeated loss is often compounded by another reality. The causes behind miscarriage are complex and often difficult to identify, and even those conditions and associations proposed as causes are poorly understood.
› Verified 2 days ago
Philip J Kurle, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1075 Nichols Rd, Osage Beach, MO 65065 Phone: 573-302-3999 Fax: 573-302-2751 | |
Dr. Cesar E Munoz, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 840 Passover Rd, Osage Beach, MO 65065 Phone: 573-302-0319 Fax: 573-693-1680 | |
Dr. James D Dexter, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 54 Hospital Dr, Osage Beach, MO 65065 Phone: 573-348-8000 Fax: 573-348-8069 |